Evidence map›Paper›PMID 39066890›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison.

Kristen Johnson, Barbara Stoffel, Michael Schwitter, Stefanie Hayoz, Alfonso Rojas Mora, Angela Fischer Maranta, Tämer El Saadany, Ursula Hasler, Roger von Moos, Annalea Patzen and 3 more

Abstract readComparative Study
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Addressing the Needs of Breast Cancer Survivors.Current oncology reports · 2025
    Review
  3. Regional limb cooling for the prevention of chemotherapy-induced toxicities: a narrative review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kristen JohnsonDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Barbara StoffelDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Michael SchwitterDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Stefanie HayozSAKK Competence Center, Bern, Switzerland.
Alfonso Rojas MoraSAKK Competence Center, Bern, Switzerland.
Angela Fischer MarantaDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Tämer El SaadanyDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Ursula HaslerDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Roger von MoosDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Annalea PatzenDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Michael MarkDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Gillian RobertsDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
Richard CathomasDivision of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland. richard.cathomas@ksgr.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCommon side effects of taxane chemotherapy are nail toxicity and peripheral neuropathy (CIPN) causing severe impact on the quality of life. Different methods of cryotherapy to prevent these side effects have been tested. We investigated the use of machine-controlled cooling of hands and feet to reduce nail toxicity and CIPN in patients receiving taxane chemotherapy.

methodsPatients receiving Docetaxel (planned dose

resultsA total of 69 patients, 21 treated with Docetaxel and 48 with Paclitaxel, were included at our centre between 08/2020 and 08/2022. Nail toxicity due to Docetaxel was overall not significantly improved by cooling in the ITT or PPP but a significant benefit across visits was found for the ITT. CIPN due to Paclitaxel was numerically better in the ITT and significantly better in the PPP. A significant benefit of cooling on CIPN occurrence across visits was found for the ITT and the PPP. Cooling was very well tolerated.

conclusionCooling of hands and feet has a clinically meaningful impact on reducing occurrence of CIPN and nail toxicity on treatment with taxanes. Effects are more significant over time and are dose dependent. TRIAL REGISTRATION NUMBER: 2020-00381. Date of registration. 24th February 2020.

Indexed as

DocetaxelNail DiseasesPaclitaxelPeripheral Nervous System DiseasesAdultAgedAntineoplastic AgentsCryotherapyFemaleHumansMaleMiddle AgedNeoplasmsProspective StudiesQuality of LifeTaxoidsAntineoplastic AgentsDocetaxelPaclitaxelTaxoidsChemotherapy-induced polyneuropathy (CIPN)DocetaxelHilotherapyNail changesPaclitaxel

Identifiers

PMID39066890
PMCPMC11283420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.